Theme
Biotechnology ETFs
Nukoud tracks 2 Biotechnology ETFs across 1 listing market (2 on United States). Combined assets under management are $10,554 million. The median expense ratio is 0.47%. The largest fund is iShares Biotechnology ETF (IBB) at $10,454 million. Use the table to compare fees, size and year-to-date performance, or open the screener to refine the list.
Data as of · Summary generated from fund data
- ETFs
- 2
- Combined AUM
- $10.55B
- Median fee
- 0.470%
- Avg YTD
- +33.77%
- Listed on
- United States · 2
- Shariah-compliant
- None
All biotechnology etfs
Sorted by assets. Click a column to re-sort; type to filter.
Largest by assets
How Biotechnology overlaps
Terms that share funds with Biotechnology. Each number is how many biotechnology etfs also carry that exposure.
Other theme lists
Frequently asked questions
- What is the largest Biotechnology ETF?
- iShares Biotechnology ETF (IBB) is the largest Biotechnology ETF tracked by Nukoud, with $10,454 million in assets.
- Which Biotechnology ETF has the lowest expense ratio?
- iShares Biotechnology ETF (IBB) charges 0.44% a year, the lowest fee among 2 Biotechnology ETFs.
- Are there Biotechnology ETFs listed in the GCC?
- Not yet. None of the 2 Biotechnology ETFs tracked by Nukoud is listed on a GCC exchange; all are available through international brokers.
- Are any Biotechnology ETFs Shariah-compliant?
- None of the 2 Biotechnology ETFs currently tracked is marketed as Shariah-compliant.
- How much do Biotechnology ETFs cost?
- Expense ratios range from 0.44% to 0.50%, with a median of 0.47% a year.
